Skip to main content
more_vert
menu
chevron_left
home
Home
Our Mission
Our People
What We Do
For Students
Events
Outputs
News
Projects
Getting Involved
What We're Reading
January 27, 2021
COVID-19 drug remdesivir has been a big win for Gilead — and it got a boost from taxpayers
Christopher Morten
Engelberg Center on Innovation Law & Policy
139 MacDougal Street Room 408, New York, NY 10012
engelberg.center@nyu.edu
@nyuengelberg
